Istituti Ospitalieri di Cremona
15
3
3
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.7%
1 terminated/withdrawn out of 15 trials
83.3%
-3.2% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study
Role: collaborator
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
Role: collaborator
Genetic Bases of COVID-19 Clinical Variability
Role: collaborator
Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy
Role: collaborator
A Stepped Wedge Cluster Randomized Controlled Trial to Assess a Strategy Aiming to Optimize Psychosocial Outcomes in Patients With Cancer
Role: lead
Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients
Role: collaborator
Local Anesthetic Infiltration VS Trasversalis Fascia Block VS Spinal Anesthesia
Role: lead
Cremona Population-Based Gastric Tumors Registry
Role: collaborator
PECS and Parasternal Block for Breast Surgery
Role: lead
PVB vs PECS Block in Breast Surgery
Role: lead
Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients
Role: lead
Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
Role: lead
Early Precut in Difficult Biliary Cannulation
Role: collaborator
The Impact of Split Dose of Low-volume Polyethylene Glycol on Adenoma Detection Rate
Role: collaborator
Transversus Abdominis Plane Block for Laparoscopic Hysterectomy
Role: lead
All 15 trials loaded